glycylglutamine has been researched along with morphine in 4 studies
| Studies (glycylglutamine) | Trials (glycylglutamine) | Recent Studies (post-2010) (glycylglutamine) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 104 | 8 | 14 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | glycylglutamine (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callahan, MF; Millington, WR; Owen, MD; Trivedi, K; Unal, CB; York, C | 1 |
| Cavun, S; Göktalay, G; Millington, WR | 1 |
| Basaran, NF; Buyukuysal, RL; Cavun, S; Millington, WR | 1 |
| Aydin, S; Basaran, NF; Buyukuysal, RL; Cavun, S; Millington, WR; Sertac Yilmaz, M | 1 |
4 other study(ies) available for glycylglutamine and morphine
| Article | Year |
|---|---|
Glycyl-glutamine inhibits the respiratory depression, but not the antinociception, produced by morphine.
Topics: Acidosis; Analgesia; Animals; Carbon Dioxide; Dipeptides; Hydrogen-Ion Concentration; Hypercapnia; Hypoxia; Injections, Intraventricular; Male; Morphine; Oxygen; Pain Measurement; Rats; Rats, Sprague-Dawley; Respiration | 2000 |
Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; beta-Endorphin; Conditioning, Operant; Dipeptides; Dose-Response Relationship, Drug; Drug Tolerance; Food; Injections, Intraventricular; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Substance Withdrawal Syndrome | 2005 |
Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Dipeptides; Dopamine; Dose-Response Relationship, Drug; Male; Microdialysis; Morphine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reward; Time Factors | 2010 |
The effect of Gly-Gln [ß-endorphin30-31] on morphine-evoked serotonin and GABA efflux in the nucleus accumbens of conscious rats.
Topics: Animals; Dipeptides; gamma-Aminobutyric Acid; Injections, Intraventricular; Male; Morphine; Narcotics; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Serotonin | 2016 |